WuXi PharmaTech (Cayman) Inc., (WuXi) is a pharmaceutical, biotechnology and medical device research and development (R&D) outsourcing company, with operations in People�s Republic of China and the United States. The Company provides a portfolio of laboratory and manufacturing services throughout the R&D process to its customers, which include the world�s pharmaceutical, biotechnology and medical device companies. The Company has added some services, including discovery biology, safety pharmacology, drug metabolism and pharmacokinetics (DMPK), bioanalytical services, manufacturing process R&D, clinical-trial-scale manufacturing, formulation, toxicology and commercial-scale manufacturing. The Company operates in two segments: Laboratory services segment and Manufacturing Services Segment. In October 2011, the Company acquired Abgent, Inc. In October 2011, the Company acquired MedKey Med-Tech Development Co. Ltd. and Jiecheng Med-Tech Development Co. Ltd.